Daily oral pre-exposure prophylaxis (PrEP) is recommended to reduce the risk of human
immunodeficiency virus (HIV) infection in adolescents and young adults (AYAs) [
[1]
]. National electronic pharmacy data suggest that emergency department (ED) providers
provide approximately 12–21% of PrEP prescriptions to AYAs [
- US Public Health Service
Pre-exposure prophylaxis for the prevention of HIV infection in the United States
— 2014: a clinical practice guideline.
http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf
Date accessed: January 14, 2018
[2]
]. The ED may be a key access for PrEP given the risk profile of the population served
[
[3]
,
[4]
]. Yet, there have been limited studies to examine what factors impact willingness
to take PrEP in ED settings.Keywords
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D; use, select 'Corporate R&D; Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pre-exposure prophylaxis for the prevention of HIV infection in the United States — 2014: a clinical practice guideline.(Available from:)http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdfDate accessed: January 14, 2018
- Adolescent use of Truvada (FTC/TDF) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: (2012–2017).in: AIDS Meeting, July 23–27, 2018. 2018
- Changes in ambulatory health care use during the transition to young adulthood.J Adolesc Health. 2010 May; 46: 407-413https://doi.org/10.1016/j.jadohealth.2009.09.010
- HIV prevention and treatment: the evolving role of the emergency department.Am Emerg Med. 2017; 70: 562-572
- Human immunodeficiency virus pre-exposure prophylaxis for adolescent men how do we ensure health equity for at-risk young men?.JAMA Pediatr. 2017; 171: 1041-1042https://doi.org/10.1001/jamapediatrics.2017.2397
- Protecting adolescent confidentiality under health care reform: the special case regarding explanations of benefits (EOBs).Philip R. Lee Institute of Health Policy and Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California, San Francisco, San Francisco2014
- Minors' and young adults' experiences of the research consent process in a phase II safety study of pre-exposure prophylaxis for HIV.J Adolesc Health. 2017 Dec; 61: 747-754https://doi.org/10.1016/j.jadohealth.2017.06.013
- Adolescent and parent perceptions on youth participation in risk behavior research.Arch Pediatr Adolesc Med. 2006 Nov; 160: 1159-1166https://doi.org/10.1001/archpedi.160.11.1159
- Options for assuring access to confidential care for adolescents and young adults in an explanation of benefits environment.J Adolesc Health. 2015 Jan; 56: 7-9https://doi.org/10.1016/j.jadohealth.2014.10.262
Article Info
Publication History
Published online: November 09, 2018
Accepted:
November 9,
2018
Received in revised form:
November 8,
2018
Received:
October 29,
2018
Identification
Copyright
© 2018 Published by Elsevier Inc.
